EUVIMEDEUVIMED entdecken
Open Access

Association Between Gender-affirming Hormone Therapy and Measures of Glucose Metabolism: A Longitudinal Study

Olivia Anike, Qi Zhang, Shalender Bhasin iD, W Dana Flanders, Darios Getahun, J Sonya Haw, Krista F Huybrechts, Timothy L Lash, Courtney E McCracken, Douglas Roblin, Michael J Silverberg, Shakira F Suglia und 3 weitere

The Journal of Clinical Endocrinology & Metabolism · 18.12.2024 · 110 (1) · 289-296

DOI: 10.1210/clinem/dgae353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 30.05.2024. Verfasst von Olivia Anike und 14 weiteren Autor:innen. Beteiligte Einrichtung: Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA. Hauptthemen laut MEDLINE: Blood Glucose, Glycated Hemoglobin, Transgender Persons. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

The long-term effect of gender-affirming hormone therapy (GAHT) on glucose metabolism is an area of priority in transgender health research.

Objectives

To evaluate the relation between GAHT and changes in fasting blood glucose (FG) and glycosylated hemoglobin (HbA1c) in transmasculine (TM) and transfeminine (TF) persons relative to the corresponding temporal changes in presumably cisgender persons (ie, without any evidence of gender diversity).

Design

Retrospective cohort study.

Setting

Three large integrated health systems.

Participants

A total of 2148 TF and 1679 TM persons compared with 28 036 cisgender males and 32 548 cisgender females enrolled in the same health plans. Outcomes/measures Temporal changes in FG and HbA1c levels examined using linear mixed models with main results expressed as ratios-of-ratios.

Results

The pre- vs post-GAHT ratios-of-ratio (95% CI) estimates adjusted for age, race/ethnicity, study site, and body mass index in the model comparing TF and cisgender males groups were 1.05 (1.01-1.09) for FG and 1.03 (0.99-1.06) for HbA1c. By contrast, the corresponding results in the models contrasting TM and cisgender cohort members were in the 0.99 to 1.00 range. The ratio-of-ratios comparing post-GAHT changes among transgender and cisgender persons were close to the null and without a discernable pattern.

Conclusion

Though the within-transgender cohort data suggest an increase in the levels of FG and HbA1c following feminizing GAHT initiation, these changes were no longer evident when compared with the corresponding changes in cisgender referents. Based on these results, clinically important effects of GAHT on routine laboratory markers of glucose metabolism appear unlikely.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood GlucoseGlycated HemoglobinTransgender PersonsHumansFemaleMaleRetrospective StudiesAdultLongitudinal StudiesMiddle AgedGender-Affirming ProceduresYoung AdultHormone Replacement TherapyTranssexualism

Stichwörter der Autor:innen

glucose metabolismhormone therapytransgender

Substanzen

Blood GlucoseGlycated Hemoglobinhemoglobin A1c protein, human

Autor:innen und Institutionen

  • Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.
  • Division of Endocrinology, Diabetes and Hypertension, Brigham and Women's Hospital, Boston, MA 02115, USA.
  • Department of Medicine, Harvard School of Medicine, Boston, MA 02115, USA.
  • Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA 91101, USA.
  • Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA 91101, USA.
  • Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA.

ORCID-Profile: Shalender Bhasin, Vin Tangpricha, Michael Goodman

Förderung

  • NIA NIH HHS
  • NIH

Zitieren

APA

Anike, O., Zhang, Q., Bhasin, S., Flanders, W. D., Getahun, D., Haw, J. S., Huybrechts, K. F., Lash, T. L., McCracken, C. E., Roblin, D., Silverberg, M. J., Suglia, S. F., Tangpricha, V., Vupputuri, S., & Goodman, M. (2024). Association Between Gender-affirming Hormone Therapy and Measures of Glucose Metabolism: A Longitudinal Study. The Journal of Clinical Endocrinology & Metabolism, 110(1), 289-296. https://doi.org/10.1210/clinem/dgae353

Vancouver

Anike O, Zhang Q, Bhasin S, Flanders WD, Getahun D, Haw JS, et al. Association Between Gender-affirming Hormone Therapy and Measures of Glucose Metabolism: A Longitudinal Study. The Journal of Clinical Endocrinology & Metabolism. 2024;110(1):289-296. doi:10.1210/clinem/dgae353

BibTeX
@article{Anike2024,
  author = {Anike, Olivia and Zhang, Qi and Bhasin, Shalender and Flanders, W Dana and Getahun, Darios and Haw, J Sonya and Huybrechts, Krista F and Lash, Timothy L and McCracken, Courtney E and Roblin, Douglas and Silverberg, Michael J and Suglia, Shakira F and Tangpricha, Vin and Vupputuri, Suma and Goodman, Michael},
  title = {Association Between Gender-affirming Hormone Therapy and Measures of Glucose Metabolism: A Longitudinal Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  volume = {110},
  number = {1},
  pages = {289--296},
  doi = {10.1210/clinem/dgae353}
}
Kostenlos starten →